NPY1R exerts inhibitory action on estradiol-stimulated growth and predicts endocrine sensitivity and better survival in ER-positive breast cancer
Raksha R. Bhat(University of Houston), Meghana V. Trivedi(University of Houston), Leon Bae(University of Houston), Carmine De Angelis(Baylor College of Medicine), Maria Letizia Cataldo(Baylor College of Medicine), Rachel Schiff(Baylor College of Medicine), Hariprasad Thangavel(Hackensack Meridian Health), Xiaoyong Fu(King University), Sarmistha Nanda(Baylor College of Medicine), Noor Mazin Abdulkareem(University of Houston), Bing Zhang(Baylor College of Medicine), Suhas Vasaikar(Baylor College of Medicine)
Cited by 27
Related Papers
How many human proteoforms are there?
|Nature Chemical Biology|2018|945